Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
1. Is Global Health Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Global Health Ltd is a good quality company.
2. Is Global Health Ltd undervalued or overvalued?
The key valuation ratios of Global Health Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
3. Is Global Health Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Global Health Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||15.4%||17.4%||17.4%||5.7%||4.2%||5.6%||8.6%||5.2%||14.3%||12.9%||-|
|Value Creation Index ⓘ||0.4||0.5||0.5||-0.5||-0.6||-0.5||-0.2||-0.5||0.0||0.0||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||11.6%||15.7%||-7.6%||5.2%||7.3%||2.2%||-16.6%||43.8%||11%||-|
|Adj EPS ⓘ||5.5||6.2||7.2||2.3||1.6||2.6||4.1||2.3||8.6||9.9||12|
|YoY Gr. Rt. %||-||12.2%||17.3%||-68.4%||-32.3%||69.7%||57.4%||-44.7%||276.9%||14.5%||-|
|BVPS (₹) ⓘ||29.6||35.6||42.5||44.4||46||49.9||54.4||57.2||68.5||92.6||99.4|
|Adj Net Profit ⓘ||133||150||176||55.5||37.5||64.7||102||56.8||219||265||321|
|Cash Flow from Ops. ⓘ||252||214||228||124||80.1||152||193||201||235||431||-|
|Debt/CF from Ops. ⓘ||0.5||0.2||0.6||1.5||2.1||0.9||0.1||0.1||0.5||0.2||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||6.7%||44.8%||33.6%||14.5%|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||20.6||18.5||18||5||3.2||5.1||7.5||3.9||13.6||12.5||12.5|
|Op. Profit Mgn % ⓘ||20.4||22||22.1||10||9.7||10.1||14.9||14.1||21.6||20.9||20.6|
|Net Profit Mgn % ⓘ||12.5||12.5||12.7||4.3||2.8||4.5||6.9||4.6||12.4||13.5||15.2|
|Debt to Equity ⓘ||0.2||0.1||0.1||0.2||0.2||0.1||0||0||0.1||0||0|
|Working Cap Days ⓘ||46||40||42||54||65||73||80||154||158||168||181|
|Cash Conv. Cycle ⓘ||-589||-14||-9||-4||5||7||6||10||9||8||113|
Return on Equity has increased versus last 3 years average to 12.50%
Net Profit is growing at healthy rate in last 3 years 33.63%
Sales growth is good in last 4 quarters at 14.96%
Sales growth has been subdued in last 3 years 10.00%
|TTM EPS (₹)||12||15.2|
|TTM Sales (₹ Cr.)||2,117||3,015|
|BVPS (₹.) ⓘ||99.4||98.9|
|Reserves (₹ Cr.) ⓘ||2,615||2,600|
|From the Market|
|52 Week Low / High (₹)||425.70 / 958.35|
|All Time Low / High (₹)||391.05 / 958.35|
|Market Cap (₹ Cr.)||25,764|
|Equity (₹ Cr.)||53.7|
|Face Value (₹)||2|
|Industry PE ⓘ||77.8|
The company was incorporated as ‘Global Health Private Limited’ on August 13, 2004 at New Delhi, India as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation by the Registrar of Companies, Delhi and Haryana at Delhi (RoC). The company was then converted into a public limited company under the Companies Act, 2013, pursuant to a special resolution passed by its Shareholders at the EGM held on July 31, 2021 and consequently, the name of the Company was changed to ‘Global Health Limited’ and a fresh certificate of incorporation dated August 11, 2021 was issued by the RoC.
The company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues amongst the players that operate in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. Under the “Medanta” brand, the company has a network of many hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital (Noida), which is under construction. The company strives to deliver advanced healthcare by establishing institutes of excellence that integrate medical care, teaching and research all while providing affordable medical services to patients.
Business area of the company
Global Health is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.
Key awards, accreditations, certifications and recognitions